Skip to main content
OpenTrials
Completed

NCT Number: NCT06168669

A Safety and Effectiveness Prospective Blinded Clinical Study to Validate xBar System as Monitoring Tool for Anastomotic Leaks Detection

Purpose: To validate the safety and effectiveness of xBar monitoring tool for detection of post-operative anastomotic leaks in subjects undergoing rectal/sigmoid resections with anastomosis.

The clinical team is blinded to the leak detection of the xBar system.

Completed

Looking for future studies?

Notify Me

Key information

Age range

22 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Soroka MC, Beersheba, Israel

Loading trial locations.

About this study

Study design: Pivotal, Prospective, Blinded, multi-center study. Study Population: This study will enroll approximately 190 eligible subjects undergoing scheduled colorectal surgery with anastomosis, without concomitant diversion.

xBar is an investigational device intended for post-op monitoring of patients undergoing GI surgery. The device is comprised of a surgical drain with embedded electrodes, connected to a small electronic device that records and relays data from the electrodes. The collected data is processed for early detection of complications.

Study description: The study is intended to validate the performance of the xBar system's anastomotic leak detection monitoring tool following colorectal resection with drain placement. During the index surgery the xBar device will be placed according to institution standard procedures and data recording will commence for a period of at least 3 days. Safety and complication detection performance will be evaluated retrospectively by comparing the diagnosis on a subject level done by the clinical team, who is blinded to xBar results, and the system.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 22 years
  • Indication for sigmoid or rectal resection surgery.
  • Usage of drain during the surgery (to be confirmed during the surgery)
  • Willing and able to comply with the study follow up.
  • Able and agree to provide an informed consent.

Exclusion criteria

  • Contraindication for surgery and/or general anesthesia.
  • Pregnancy or lactation.
  • Planned or unplanned fecal diversion during the surgery (to be confirmed during the surgery)
  • Known electronic device implanted in the chest or the abdominal cavity (e.g., pacemaker, cardioverter/defibrillator).
  • Major medical or psychiatric illness or condition, or other factors that may affect general health or ability to adhere to the follow-up schedule.
  • Known allergic reactions to materials used in the components of the xBar system, i.e., silicone, rubber and stainless-steel.
  • Participation in another interventional study during the xBar system usage.

Treatment and study plan

xBar system

Diagnostic Test

xBar system is surgical drain with embedded sensors. Collected data will be evaluated for an ability to identify anastomotic leaks. The xBar system does not have therapeutic indication.

Primary outcomes

  1. Safety

    Time frame: through study completion, an average of 1 year

    Lack of unanticipated serious adverse events related to the xBar system or xBar procedure during the study period.

  2. Safety - Severe leak rate - comparable to SOC.

    Time frame: through study completion, an average of 1 year

    Statistical evaluation of prevalence of anastomotic leaks in the study group compared to the prevalence present in the literature.

  3. Performance - successful xBar placement.

    Time frame: through study completion, an average of 1 year

    The device is working properly and records data in 90% of the cases or more.

  4. Performance - Sensitivity and Specificity of severe leak detection

    Time frame: through study completion, an average of 1 year

    Sensitivity and Specificity are non-inferior compared to Standard of care at POD 3

Sponsors and collaborators

Lead sponsor

Exero Medical Ltd.

Industry

Registry information

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Dec 13, 2023
Registry last updated
Jun 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.